HPV拓展分型检测在宫颈癌筛查中的临床意义

摘要
图/表
参考文献
相关文章 (8)

全文: PDF (702 KB) HTML (30 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨除HPV16/18外的HPV拓展分型检测对宫颈高级别上皮内病变和宫颈癌的筛查意义。方法回顾性研究分析,选取2018年1月—2020年12月在上海市第六人民医院(临港院区)就诊的1 200名HPV分型检测阳性的女性,并对同期因各种指征转诊阴道镜且行活组织病理检查的868例妇女,按照是否发生宫颈高级别上皮内病变和宫颈癌分为观察组和对照组,对不同年龄段、以及各亚型HPV感染的结果进行统计学分析,并计算TCT和高危亚型HPV及各亚型组合对宫颈高级别上皮内病变和宫颈癌的预测效能。结果 (1)1 200名HPV感染的女性中,感染率前三位的亚型依次为HPV52、HPV16、HPV58,60岁以上女性多重感染率更高(χ²＝5.56,P＝0.022);(2)HPV16、HPV31、HPV33亚型感染与HSIL和宫颈癌的发生有关,Logistic回归分析显示这三种亚型感染均是独立危险因素;(3)60岁及以上的患者HSIL和宫颈癌的检出率最高,差异有统计学意义(χ²＝8.322,P＝0.004);(4)预测HSIL和宫颈癌的因子中,HPV16/31/33对HSIL和宫颈癌的预测约登指数最高。结论本地区除HPV16/18亚型,对其他高危亚型如HPV31、HPV33、HPV52、HPV58等亚型的拓展分型检测有助于避免HSIL和宫颈癌的漏诊;各年龄段的妇女对大多数高危亚型HPV的易感性无明显差异,应加强本地区60岁以上妇女的宫颈癌筛查及随访,提倡个体化筛查和随访方案。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	肖静
	李莉
	邹锋
	陈宇

关键词 ： HPV分型检测, 宫颈癌筛查, logistic回归分析

Abstract：Objective To investigate the significance of HPV extended typing except HPV16/18 in high-grade intraepithelial lesions of HSIL and cervical cancer screening. Methods A total of 1200 women with HPV infection who attended Lingang campus of Shanghai sixth people's hospital from Jan. 2018 to Dec. 2020 were selected for retrospective analysis. At the meantime, a total of 868 women including some of them and other women who underwent colposcope and histopathology examination were divided into two groups according to the occurrence of HSIL or cervical cancer. The results of HPV infection in different age groups and subtypes were statistically analyzed. The efficacy of TCT, high-risk HPV subtypes and their combinations in predicting HSIL and cervical cancer was calculated. Results 1.The top three subtypes were HPV52, HPV16 and HPV58, respectively, among the 1200 women infected with HPV. And the multiple infection rate was higher in women over 60 years old(χ2＝5.56,P＝0.022). 2. HPV16, HPV31 and HPV33 were associated with the occurrence of HSIL and cervical cancer, and Logistic regression analysis showed that the infection of these three subtypes were independent risk factors. 3. The highest rates of HSIL and cervical cancer were found in patients aged 60 years and older(χ2＝8.322,P＝0.004). Conclusion 1. In addition to HPV16/18 subtype, expanded typing of other high-risk subtypes such as HPV31, HPV33, HPV52 and HPV58 in this region is helpful to avoid missed diagnosis of HSIL and cervical cancer; 2. There is no significant difference in the susceptibility of women of all ages to most high-risk subtypes of HPV, so cervical cancer screening and follow-up for women over 60 years old in this region should be strengthened, and individualized screening and follow-up programs should be advocated.

Key words： HPV typing cervical cancer screening logistic regression analysis

收稿日期: 2022-01-05

ZTFLH:	R71
	R17

基金资助:上海市第六人民医院院级科研基金(项目编号:DY2020020)

通讯作者: 陈宇(chenyuccyy@163.com)

引用本文:

肖静, 李莉, 邹锋, 陈宇. HPV拓展分型检测在宫颈癌筛查中的临床意义[J]. 中国生育健康杂志, 2023, 34(3): 243-247. XIAO Jing, LI Li, ZOU Feng, CHEN Yu. Study on HPV extended typing test in cervical cancer screening. Chinese Journal of Reproductive Health, 2023, 34(3): 243-247.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2023/V34/I3/243

1 魏丽惠,李明珠,王悦.《世界卫生组织子宫颈癌癌前病变筛查和治疗指南(第2版)》解读.中国医学前沿杂志(电子版),2021,13:44-48.
2 林彤彤,王新宇.人乳头瘤病毒基因分型检测在宫颈癌筛查中的应用进展.肿瘤学杂志,2021,27:27-30.
3 Hausen H.Papillomaviruses in the causation ofhuman cancers - a brief historical account.Virology.2009; 384:260-265.
4 王轶英,王悦,乔友林,等.中国宫颈癌筛查未来之路——细胞学初筛的弃或守.中国实用妇科与产科杂志,2017,33:324-326.
5 WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention,second edition [Internet].Geneva:World Health Organization; 2021.
6 魏丽惠.阴道镜及宫颈细胞病理学规范化培训教材.第1版.北京:人民卫生出版社,2020:5.
7 中国优生科学协会阴道镜和宫颈病理学分会专家委员会.中国宫颈癌筛查和异常管理相关问题专家共识(二).中国妇产科临床杂志,2017,18:286-288.
8 李帆,郝崔培.HPV分型检查配合TCT检测在宫颈病变早期筛查效果.中国计划生育学杂志,2021,29:1069-1071+1076.
9 潘发明.医学统计学方法及其SPSS软件实现.第3版.合肥:中国科学技术大学出版社,2018:435.
10 Lekoane KMB,Kuupiel D,Mashamba-Thompson TP,et al.The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa:scoping review.Syst Rev.2020; 9:88.
11 Cho HW,So KA,Lee JK,et al.Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1:A prospective cohort study.Obstet Gynecol Sci.2015;58:40-45.
12 Saslow D,Solomon D,Lawson HW,et al.American cancer society,American society for colposcopy and cervical pathology,and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer.CA Cancer J Clin,2012,16:147-172.
13 Hirth J.Disparities in HPV vaccination rates and HPV prevalence in the United States:a review of the literature.Hum Vaccin Immunother.2019; 15:146-155.
14 Li B,Wang H,Yang D,et al.Prevalence and distribution of cervical human papillomavirus genotypes in women withcytological results from Sichuan province,China.J Med Virol.2019; 91:139-145.
15 张梦培,尹如铁,李克敏,等.中国西部女性生殖道高危人乳头状病毒感染状况的Meta分析.中国循证医学志,2019,19:1268-1275.
16 Schiffman M,Hyun N,Raine-Bennett TR,et al.A cohort study of cervical screening using partialHPV typing and cytology triage.Int J Cancer.2016; 139:2606-2615.
17 王兰芳,胡双婕,葛晓伟,等.HPV不同基因型感染在宫颈病变过程中的研究.中华疾病控制杂志,2019,23:536-539;544.